David Gerring

Chief Development Officer (CDO) @Arecor Therapeutics

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2024 — Present

Chief Development Officer (CDO) @Arecor Therapeutics

View department →

Cambridge, GB

EDUCATION

1996 — 1999

Reading University

School; Bachelor of Science, Animal and Microbial Sciences Biochemistry; 2

SKILLS

Drug DevelopmentBiopharmaceuticalsPcrHplcProtocol and Report WritingSds-PageValidationMass SpectrometryBiochemistryVaccinesQmsAnalytical Method ValidationTechnology TransferTissue CultureCellRegulatory SubmissionsDlsGlpElisaLife SciencesSurface Plasmon ResonanceAucPurificationQuality AssuranceMethod Development6sProject ManagementDmsTroubleshootingHplc-MsQuality SystemBiotechnologyProtein PurificationRecombinant Dna TechnologyQuality ControlGmpPharmaceutical IndustrySopFdaProject Planning

ABOUT DAVID GERRING

A protein biochemist and immunologist with 15 years experience in academic and biopharmaceutical sectors. Experience of working on product and process development and characterisation for a range of biological therapies including monoclonal and polyclonal antibodies, enzymes, peptides, vaccines, bi-specifics, ADCs, T-cell receptor therapies and viral vectors. Key skills:Leadership and strategyCMCFormulation and stabilityAnalytical assay development, qualification and validationCharacterisationExtensive experience of regulatory interactions (IMP, CTA, NDA, BLA, MA, PAS)DSP and DP process development and fill and finishPharmacologyToxicologyTechnology transfer Vendor managementGMP

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

David Gerring — Chief Development Officer (CDO) at Arecor Therapeutics in Cambridge, GB | Unifers